Correction to: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

BMC Cancer (Dec 2018)

Affiliations

Wan-Ling Tan: Division of Medical Oncology, National Cancer Centre Singapore
Quan Sing Ng: Division of Medical Oncology, National Cancer Centre Singapore
Cindy Lim: Clinical Trials & Epidemiological Sciences, National Cancer Centre Singapore
Eng Huat Tan: Division of Medical Oncology, National Cancer Centre Singapore
Chee Keong Toh: Division of Medical Oncology, National Cancer Centre Singapore
Mei-Kim Ang: Division of Medical Oncology, National Cancer Centre Singapore
Ravindran Kanesvaran: Division of Medical Oncology, National Cancer Centre Singapore
Amit Jain: Division of Medical Oncology, National Cancer Centre Singapore
Daniel S. W. Tan: Division of Medical Oncology, National Cancer Centre Singapore
Darren Wan-Teck Lim: Division of Medical Oncology, National Cancer Centre Singapore

Abstract

ᅟ

ISSN: 1471-2407 (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: http://bmccancer.biomedcentral.com